Zogenix Inc. buy marge
Start price
07.09.18
/
50%
€40.27
Target price
04.11.21
€79.00
Performance (%)
-66.60%
End price
05.11.21
€13.45
Summary
This prediction ended on 05.11.21 with a price of €13.45. The BUY prediction by marge for Zogenix Inc. performed very badly with a performance of -66.60%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% | 55.750% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% | 80.820% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% | 49.596% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% | 55.940% |
Comments by marge for this prediction
In the thread Zogenix Inc. diskutieren
Zogenix mit Aufwärtspotential
Zogenix with positive results from a Phase 2 clinical trial evaluating ZX008 in patients with Lennox-Gastaut syndrome (LGS), a rare and severe type of childhood epilepsy.
Zogenix initiated with Buy rating and $116 (154% upside) price target at B. Riley FBR citing upside for ZX008.
In the thread Trading Zogenix Inc.
Die von marge gewählte maximale Laufzeit wurde überschritten